March 31, 2021 – Kyocera Medical Technologies, Inc. is pleased to announce our new YouTube channel which highlights our spine, joint, and biologics products and technologies. Currently featured videos include the following: In a webinar on the ReBOSSIS® bone scaffold, Dr. Boyle Cheng presents the cell culture and in vivo studies that demonstrate how ReBOSSIS enhances bone […]
December 7, 2020 – ReBOSSIS® from Kyocera Medical Technologies, Inc. is the only biosynthetic bone scaffold with electrospun microfiber construction. This process results in a material with excellent handleability, similar to cotton. ReBOSSIS is hydrophilic, meaning it absorbs and retains bioactive fluids, enhancing osteoinductive potential […]
January 16, 2019 – Kyocera Corporation (President: Hideo Tanimoto) today announced that its U.S. headquarters, Kyocera International, Inc., has finalized an agreement with Renovis Surgical Technologies, Inc. (herein “Renovis”), a U.S.-based orthopedic and spinal medical device manufacturer and developer, to purchase the major assets of Renovis’ business operations relating to artificial […]
August 9, 2017 – Renovis Surgical Technologies, Inc. announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market posterior lumbar Tesera® porous titanium interbody fusion systems. These systems feature implants for direct posterior (PLIF) or transforaminal (TLIF) approaches […]
March 30, 2016 – Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Tesera™ SC – Porous Titanium Cervical Interbody Fusion System. Tesera SC is a porous titanium stand-alone cervical interbody fusion […]
April 15, 2014 – Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Tesera Trabecular Technology™ Acetabular System. This novel hip implant is manufactured utilizing additive manufacturing and a patent-pending design to […]
October 3, 2013 – Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the Tesera™ Stand-alone ALIF Cage. This titanium implant uses additive manufacturing and a patent-pending design to create porous surfaces that […]
February 14, 2013 – Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the A200 Cruciate Retaining Total Knee System. This new knee system was designed for anatomic fit and long-term performance and […]
June 13, 2012 – Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the A450 Acetabular Cup and A400 Tapered Cementless Hip Stem. This new line of hip replacement implants includes versatile femoral […]
December 9, 2011 – Renovis Surgical Technologies, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the T700™ Cannulated Screw system. As the first offering in the company’s trauma product line, this marks a major milestone […]
KYOCERA Medical is committed to providing high quality orthopedic products that help surgeons meet the unique demands of every patient.
FIND US
HEADQUARTERS / WAREHOUSE
1289 Bryn Mawr Ave., Suite A.,
Redlands, CA 92374
R&D CENTER
10431 Morado Circle, Building V, Suite 150
Austin, TX 78759
©2025 Kyocera Medical Technologies, Inc. All rights reserved.